Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2014

Nov 26, 2014

284_dirs_2014-11-26_b032405d-6149-412a-b963-3e973f14044d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-11-26

Reporting Person: LAZARUS ROCHELLE B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-11-26 Common Stock M 5000.0000 $34.4400 Acquired 9595.0000 Direct
2014-11-26 Common Stock M 5000.0000 $33.8300 Acquired 14595.0000 Direct
2014-11-26 Common Stock S 10000.0000 $59.6300 Disposed 4595.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-11-26 Stock Option (right to buy) $34.4400 M 5000.0000 Disposed 2016-04-27 Common Stock (5000.0000) Direct
2014-11-26 Stock Option (right to buy) $33.8300 M 5000.0000 Disposed 2015-04-28 Common Stock (5000.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1757.0000 Indirect

Footnotes

F1: The option became exercisable in equal installments on 4/28/2007, 4/28/2008 and 4/28/2009.

F2: The option became exercisable in equal installments on 4/29/2006, 4/29/2007 and 4/29/2008.